An interventional study of Hemopatch and No Hemopatch in Renal Failure, sponsored by St. Joseph's Healthcare Hamilton. Completed at 1 site in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-12-16.
Sponsored by St. Joseph's Healthcare Hamilton · Not applicable, Interventional, and Treatment
Kidney transplantation remains one of the most common organ transplanted today but the surgical technique has changed very little from the original pelvic operation. The deceased donor renal transplant poses a particular challenge to the surgeon due to lack of detailed pre operative vascular assessment. The hemopatch is a promising new sealing synthetic hemostatIc agent with a novel dual mechanism of action that is more convenient to apply rather then using other hemostatic agents, which require warming and/or mixing.
1,995 studies on the registry are indexed under Renal Insufficiency; 173 are open to participants now.
This study's enrollment of 20 is below the median of 43 across 1,504 interventional studies indexed under Renal Insufficiency.
Browse Renal Insufficiency studies →St. Joseph's Healthcare Hamilton is the lead sponsor of 137 studies on the registry; 31 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
The hemopatch is a promising new sealing synthetic hemostatic agent with a noval dual mechanism of action. The hemopatch is a polyethylene glycol coated (PEG coated) collagen patch. The PEG coating helps in rapid adhesion to the tissue surface while the collagen layer causes platelet activation and adhesion.
Device: Hemopatch
Standard hemostatic agents (floseal, tisseal).
Device: No Hemopatch
Blood Loss
Blood loss will be measured in ml (cc).
Time frame: Baseline (Intraoperatively)
Hemostasis achievement
Hemostasis achievement will be measured in minutes.
Time frame: Baseline (Intraoperatively)
Drop in Hemoglobin
Hemoglobin will be measured in g/L (drop measured from pre-operative levels to post-operative 48 hours).
Time frame: up to 48 hours postoperatively
Amount of Perigraft Collection
measured in ml (with ultrasound done within 48 hours of surgery).
Time frame: up to 48 hours postoperative
This study is completed, as verified in Dec 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
St. Joseph's Healthcare Hamilton